Cancer Research Cell Death Mechanisms and Cancer Therapy
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Clinical Research: Clinical Trials

Contributing journals to this collection:
Cancer Prevention Journals Portal, Cancer Prevention Journals Portal Content, , Cancer Reviews Online, Molecular Cancer Research, Cancer Prevention Research, Molecular Cancer Therapeutics, Cancer Research, Cancer Reviews Online Content, Clinical Cancer Research, and Cancer Epidemiology Biomarkers & Prevention

Citations 31-40 of 47 total displayed.

Past content

Clin. Cancer Res.
Review
Interleukin-12: Biological Properties and Clinical Application
Michele Del Vecchio, Emilio Bajetta, Stefania Canova, Michael T. Lotze, Amy Wesa, Giorgio Parmiani, and Andrea Anichini
Clin. Cancer Res. 2007; 13: 4677-4685. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Reviews
Lessons learned in the development of targeted therapy for malignant gliomas
Antonio M.P. Omuro, Sandrine Faivre, and Eric Raymond
Mol. Cancer Ther. 2007; 6: 1909-1919. [Abstract] [Full text] [PDF]  

Clin. Cancer Res.
Review
The Potential of Antiangiogenic Therapy in Non–Small Cell Lung Cancer
Giuseppe Giaccone
Clin. Cancer Res. 2007; 13: 1961-1970. [Abstract] [Full text] [PDF]  

Clin. Cancer Res.
CCR Focus
Targeted Therapy for Brain Metastases: Improving the Therapeutic Ratio
Rakesh R. Patel and Minesh P. Mehta
Clin. Cancer Res. 2007; 13: 1675-1683. [Abstract] [Full text] [PDF]  

Mol. Cancer Res.
Subject Review
The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR Agents
Josep Tabernero
Mol. Cancer Res. 2007; 5: 203-220. [Abstract] [Full text] [PDF]  

Mol. Cancer Ther.
Reviews
Targeted therapeutics for multiple myeloma: The arrival of a risk-stratified approach
Rafael Fonseca and A. Keith Stewart
Mol. Cancer Ther. 2007; 6: 802-810. [Abstract] [Full text] [PDF]  

Clin. Cancer Res.
Reviews
Current Development of Clinical Inhibitors of Poly(ADP-Ribose) Polymerase in Oncology
Kapila Ratnam and Jennifer A. Low
Clin. Cancer Res. 2007; 13: 1383-1388. [Abstract] [Full text] [PDF]  

Clin. Cancer Res.
Reviews
Vascular Endothelial Growth Factor–Targeted Therapy in Renal Cell Carcinoma: Current Status and Future Directions
Brian I. Rini
Clin. Cancer Res. 2007; 13: 1098-1106. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Systemic Efficacy with Oncolytic Virus Therapeutics: Clinical Proof-of-Concept and Future Directions
Ta-Chiang Liu and David Kirn
Cancer Res. 2007; 67: 429-432. [Abstract] [Full text] [PDF]  

Cancer Res.
Reviews
Pathophysiologic Effects of Vascular-Targeting Agents and the Implications for Combination with Conventional Therapies
Michael R. Horsman and Dietmar W. Siemann
Cancer Res. 2006; 66: 11520-11539. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5

* Collected Resources Home


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH SEARCH RESULT
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.